Partner Article
Salford-based BioClinics gets green light to expand testing
Salford testing firm BioClinics is set for further growth after securing approval to supply its services to several key target markets.
BioClinics conducts its tests by collecting and analysing urine and breath samples. It operates a network of clinics and mobile sample collectors across the UK and Ireland.
The firm has gained accreditations from Achilles Group, which evaluates suppliers on behalf of companies and organisations operating in nearly a dozen sectors.
BioClinics has passed industry audits for its workplace drug and alcohol tests in the transport, rail and utilities sectors.
The accreditations mean BioClinics is now an approved supplier of pre-employment and random tests to the rail and transport sectors, including Network Rail and its sub-contractors, and to utility companies including National Grid and its sub-contractors.
BioClinics experiencing a 470% rise in the number of annual tests it carried out between 2010 and 2013.
Nichola McChrystal, founder and scientific director of BioClinics, said: “We are aiming to double the number of tests we carry out over the next six months. In the longer term, major investment projects such as the HS2 and HS3 rail links should generate even greater demand for our testing services.”
This was posted in Bdaily's Members' News section by Sophia Taha .
Ready to scale? Buy-and-build offers opportunity
When will our regional economy grow?
Creating a thriving North East construction sector
Why investors are still backing the North East
Time to stop risking Britain’s family businesses
A year of growth, collaboration and impact
2000 reasons for North East business positivity
How to make your growth strategy deliver in 2026
Powering a new wave of regional screen indies
A new year and a new outlook for property scene
Zero per cent - but maximum brand exposure
We don’t talk about money stress enough